Sanjay Sethi Selected Research

Type 4 Cyclic Nucleotide Phosphodiesterases

1/2016

Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjay Sethi Research Topics

Disease

93	Chronic Obstructive Pulmonary Disease (COPD) 09/2023 - 01/2002
15	Infections 01/2022 - 03/2003
11	Inflammation (Inflammations) 01/2016 - 01/2002
10	Chronic Bronchitis 11/2018 - 10/2003
9	Pneumonia (Pneumonitis) 07/2023 - 10/2003
5	Asthma (Bronchial Asthma) 01/2023 - 05/2012
5	Bacterial Infections (Bacterial Infection) 06/2015 - 10/2007
3	Human Influenza (Influenza) 01/2012 - 04/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
2	COVID-19 01/2022 - 01/2020
2	Asymptomatic Infections 02/2006 - 07/2005
2	Respiratory Tract Infections (Respiratory Tract Infection) 04/2005 - 10/2003
1	Dyspnea (Shortness of Breath) 07/2023
1	Leiomyoma (Uterine Fibroids) 03/2023
1	Dyspepsia (Indigestion) 01/2022
1	Heart Failure 01/2022
1	Obesity 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Pseudomonas Infections 12/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Atrial Fibrillation 01/2019

Drug/Important Bio-Agent (IBA)

20	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2003
17	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 04/2009
12	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 10/2007
9	Muscarinic AntagonistsIBA 07/2023 - 01/2016
9	AntibodiesIBA 01/2011 - 03/2003
7	Tiotropium Bromide (Spiriva)FDA Link 07/2023 - 01/2016
7	Proteins (Proteins, Gene)FDA Link 05/2022 - 03/2003
7	Formoterol Fumarate (Oxis)FDA Link 05/2020 - 11/2016
7	revefenacinIBA 01/2020 - 01/2019
7	EpitopesIBA 10/2009 - 03/2003
5	MacrolidesIBA 01/2016 - 01/2002
5	SmokeIBA 08/2015 - 04/2009
5	Moxifloxacin (Avelox)FDA Link 01/2015 - 07/2005
5	AntigensIBA 05/2012 - 03/2003
5	Immunoglobulin G (IgG)IBA 02/2006 - 03/2003
4	GoldIBA 01/2023 - 01/2016
4	Cholinergic Antagonists (Anticholinergics)IBA 01/2019 - 02/2011
4	FluoroquinolonesIBA 01/2016 - 01/2002
4	Immunoglobulin A (IgA)IBA 12/2015 - 07/2005
4	Interleukin-8 (Interleukin 8)IBA 01/2015 - 05/2006
4	EnzymesIBA 02/2014 - 03/2003
4	Membrane Proteins (Integral Membrane Proteins)IBA 05/2009 - 03/2003
3	SteroidsIBA 01/2022 - 05/2016
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2021 - 01/2019
3	Budesonide (Pulmicort)FDA LinkGeneric 01/2021 - 01/2019
3	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 05/2020 - 01/2016
3	RoflumilastIBA 11/2018 - 01/2016
3	SuspensionsIBA 02/2017 - 06/2015
3	sulforaphaneIBA 01/2017 - 04/2011
3	CytokinesIBA 01/2017 - 09/2014
3	LigandsIBA 01/2016 - 09/2014
3	Peptide Hydrolases (Proteases)FDA Link 12/2015 - 11/2009
3	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 07/2012 - 01/2005
3	ImmunosorbentsIBA 02/2006 - 03/2003
2	olodaterolIBA 07/2023 - 01/2023
2	fluticasone furoate FDA Link 07/2023 - 01/2023
2	vilanterolIBA 07/2023 - 01/2023
2	GSK573719IBA 07/2023 - 01/2023
2	ProteomeIBA 05/2022 - 02/2014
2	aclidinium bromideIBA 02/2020 - 01/2019
2	Therapeutic UsesIBA 10/2019 - 06/2015
2	AntioxidantsIBA 08/2019 - 01/2016
2	SolutionsIBA 01/2019 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 01/2015
2	IgA-specific serine endopeptidaseIBA 12/2015 - 01/2011
2	Complement System Proteins (Complement)IBA 12/2013 - 01/2011
2	VaccinesIBA 12/2009 - 03/2003
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2005 - 01/2002
2	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2005 - 01/2002
1	tiotropium-olodaterolIBA 07/2023
1	mepolizumabIBA 01/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Indicators and Reagents (Reagents)IBA 09/2020
1	2- n- butyl- 3- (dimethylamino)- 5,6- methylenedioxyindeneIBA 05/2020
1	AerosolsIBA 01/2020
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2020
1	AB 400IBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	Interleukin-18 (Interleukin 18)IBA 01/2017
1	Cytidine Triphosphate (CTP)IBA 05/2016

Therapy/Procedure

31	Therapeutics 09/2023 - 01/2002
5	Metered Dose Inhalers (Metered Dose Inhaler) 05/2020 - 01/2016
3	Nebulizers and Vaporizers (Inhaler) 09/2023 - 01/2020
2	Fitness Trackers 09/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 02/2020 - 01/2020
2	Microspheres (Microsphere) 09/2014 - 12/2013
1	Hospital to Home Transition 09/2023
1	Patient Transfer (Patient Dumping) 09/2023
1	Uterine Myomectomy 03/2023
1	Hysterectomy 03/2023
1	Uterine Artery Embolization 03/2023
1	Retreatment 01/2020
1	Patient Readmission 01/2018